πŸ‡ΊπŸ‡Έ FDA
Patent

US 9074185

Adoptive cell therapy with young T cells

granted A61KA61K2039/515A61K2239/31

Quick answer

US patent 9074185 (Adoptive cell therapy with young T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/515, A61K2239/31, A61K2239/38, A61K2239/57